IBM (IBM) Offering Possible 13.9% Return Over the Next 17 Calendar Days

IBM's most recent trend suggests a bearish bias. One trading opportunity on IBM is a Bear Call Spread using a strike $114.00 short call and a strike $119.00 long call offers a potential 13.9% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $114.00 by expiration. The full premium credit of $0.61 would be kept by the premium seller. The risk of $4.39 would be incurred if the stock rose above the $119.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for IBM is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for IBM is bearish.

The RSI indicator is at 25.09 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for IBM

Top Insider Buys Highlight for the Week of Oct. 30
Sun, 01 Nov 2020 20:57:16 +0000
Insiders load up on IBM, Raytheon Technologies, Crown Castle and Kimberly-Clark

Last Week's Notable Insider Buys: IBM, Intel, Raytheon And More
Sat, 31 Oct 2020 18:39:00 +0000
* Insider buying can be an encouraging signal for potential investors when markets face uncertainty. * Insiders were buying shares of a couple of semiconductor makers and an old-school tech giant last week. * Some chief executives were among the insiders making trips to the buy window. Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when markets are near all-time highs.Though buy windows have closed for many insiders during earnings-reporting season, plenty of others continued to add shares despite market volatility and economic uncertainty. Here are some of the most noteworthy insider purchases reported in the past week.The Live Oak Bancshares Inc. (NASDAQ: LOB) CEO, James Mahan, via trust purchased over 154,300 shares of this North Carolina-based bank at prices ranging from $33.02 to $35.00 apiece. That cost him more than $5.27 million. Note that Mahan also bought 233,000 shares back in August.An executive and two other insiders at newly public Foghorn Therapeutics Inc (NASDAQ: FHTX) bought more than 305,000 shares at the IPO price of $16.00. That totaled almost $4.90 million. Note that one of those insiders, listed as a former 10% owner, was the Abu Dhabi Investment Authority.Raytheon Technologies Corp. (NYSE: RTX) saw Chief Executive Officer Gregory Hayes pick up 55,000 shares of this aerospace and defense company. Four other insiders cumulatively bought more than 30,000 shares as well. At $52.28 to $55.20 per share, those transactions totaled over $4.59 million altogether.A beneficial owner at Safety Insurance Group Inc. (NASDAQ: SAFT) returned to add to a stake. The more than 48,500 shares of this Boston-based company indirectly scooped up, at prices ranging from $68.25 to $69.94, totaled almost $3.35 million. That owner bought 100 shares in the previous week as well.IBM (NYSE: IBM) had four directors acquire over 16,700 shares altogether of this old-school tech giant last week. At $107.49 to $110.75 per share, that added up to more than $1.82 million. Note that a different insider sold less than 7,000 shares back in August for more than $126 apiece.A director at Crown Castle International Corp. (NYSE: CCI) picked up more than 8,000 shares of this communications infrastructure company, some of them via family trust. At prices ranging from $160.85 to $161.75 per share, the total for those purchases came to more than $1.29 million.A director paid between $132.47 and $132.85 each for 3,000 Kimberly Clark Corp. (NYSE: KMB) shares late last week. That cost him around $398,000 and brought his stake in this Dallas-based consumer products company to more than 48,400 shares.See also: 5 Election-Proof Stock Ideas Ahead Of Biden-Trump DecisionIntel Corp. (NYSE: INTC) CEO Bob Swan stepped up to the buy window midweek. At $44.96 apiece, the more than 8,000 shares he acquired added up to more than $360,600. Note that the purchase price is not much above the 52-week low of $43.61 seen on Friday.A Genuine Parts Co. (NYSE: GPC) director added 2,200 more shares of this Atlanta-based vehicle parts maker last week. At around $91.72 per share, that cost him more than $201,700. Note that this director also bought 2,000 shares of Oxford Industries in September.And NXP Semiconductors NV (NASDAQ: NXPI) saw a director add shares to her stake. At $134.30 a share, the 1,500 shares cost her more than $201,400 and more than doubled the stake. Note that another director sold almost twice as many shares on the same day for a slightly higher price.Note that there also was some smaller amount of insider buying at Bank of Hawaii Corp. (NYSE: BOH), Crown Holdings Inc. (NYSE: CCK), Perspecta Inc. (NYSE: PRSP) and Texas Capital Bancshares Inc. (NASDAQ: TCBI) posted last week.At the time of this writing, the author had no position in the mentioned equities.Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.See more from Benzinga * Click here for options trades from Benzinga * Last Week's Notable Insider Buys: Del Taco, First American And More * Barron's Picks And Pans: Coca-Cola, Sprouts Farmers Market, Mirati Therapeutics And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

IBM Stock Is Slumping, but Director Sidney Taurel Bought Shares
Fri, 30 Oct 2020 14:54:00 +0000
Longtime director Sidney Taurel paid $553,725 for 5,000 shares of software giant IBM. It was his first purchase of IBM stock in two years.

3 Different IBM Insiders Just Bought (A Lot of) Stock: Should You Follow?
Fri, 30 Oct 2020 14:02:00 +0000
It's hard to imagine a big tech stock more down on its luck than International Business Machines (NYSE: IBM). While the Nasdaq index is up 28.4% on the year, IBM is down 17.5% as of this writing. The company's new CEO Arvind Krishna just took over the top job in April and recently announced a spinoff of IBM's slower-growth IT services business to refocus on its hybrid cloud and artificial intelligence technology.

IBM Named a Leader in Customer Identity and Access Management (CIAM) By Independent Research Firm
Fri, 30 Oct 2020 13:00:00 +0000
IBM (NYSE: IBM) Security today announced that it was recognized as a leader in The Forrester Wave™: Customer Identity and Access Management, Q4 2020 report. The report cited IBM's support for FIDO2, biometrics, and a broad range of authentication protocols, integration with IBM and third-party identity verification and fraud management solutions, as well as reporting and dashboarding capabilities.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.